{
 "as_of": "2026-11-08",
 "cmr": "us-cm-kg/NASDAQ/ABCL",
 "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.",
 "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# AbCellera Biologics Inc. (NASDAQ: ABCL) — research page\n\nAs of 2026-11-08 · us-cm-kg · record version 1\n\n## Identity and listing\n\nThe issuer is AbCellera Biologics Inc., listed on NASDAQ under ticker ABCL, with ISIN US00288U1060. The LEI is not on the record: no GLEIF record with the exact legal name in jurisdiction US-A1 was found. The security type is Corporate, the segment is not on the record, the sector is 2834 Pharmaceutical Preparations, and the jurisdiction is British Columbia, Canada. The issuer is listed and not halted.\n\n## The disclosure read\n\nThe record holds 50 filings in the twelve months from 2025-11-08 to 2026-11-08, across 29 filing days. By type, the filings are 25 directors_dealings, 7 corporate_news, 6 results, 4 director_change, 3 agm_egm, 3 regulatory_filing and 2 prospectus. The median gap between filing days is 5.5 days. The latest filing is dated 2026-08-24, a directors_dealings filing, 76 days before the record date. On NASDAQ the median cadence gap is 6.0 days, the median filing count is 52, and the median latency is 5.0 days across 4359 issuers. In sector 2834 Pharmaceutical Preparations the median cadence gap is 6.0 days, the median filing count is 63.0, and the median latency is 4.0 days across 526 issuers.\n\n## Auditor\n\nThe auditor of record is KPMG LLP, located in Vancouver, Canada. The record shows one auditor change, dated 2025-11-28.\n\n## Events and halts\n\nThe record holds no listing, delisting or name change lines. Domicile change is not on the record, because EDGAR states no dated change of state of incorporation on a filing line. Segment move is not on the record, because the exchanges' tier transfers are not EDGAR filings. The halt flag is listed, not halted.\n\n## Orderability\n\nThe outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.\n\n## Coverage\n\nNo research houses were found on the issuer's investor-relations pages read. The count is 0.\n\n## Open research\n\nNo openly published research notes were found. The count is 0.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nThe issuer's years sealed are 2021, 2022, 2023, 2024, 2025 and 2026. The market's vintage is sealed, with the earliest sealed date of the market at 2021-01-04. The live record began on 2026-09-12.\n\n## Sources\n\n8 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)\n- https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin)\n- https://data.sec.gov/submissions/CIK0001703057.json (identity.jurisdiction)\n- https://mcp.us-cm-kg.ai/events/NASDAQ/ABCL (the disclosure lines)\n- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)\n- https://www.sec.gov/Archives/edgar/data/1703057/000170305726000012/abcl-20251231.htm (the auditor)\n- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://mcp.us-cm-kg.ai/record/NASDAQ/ABCL (the record)\n",
 "market": "US",
 "node": "us-cm-kg",
 "numbers": {
  "as_of_depth": {
   "issuer_years_sealed": [
    "2021",
    "2022",
    "2023",
    "2024",
    "2025",
    "2026"
   ],
   "live_record_began": "2026-09-12",
   "node_history_from": "2021-01-04",
   "node_years_sealed": [
    "2021",
    "2022",
    "2023",
    "2024",
    "2025",
    "2026"
   ],
   "record_version": 1,
   "sealed": true
  },
  "auditor": {
   "auditor": {
    "read_by": "EDGAR 10-K cover page iXBRL tag (dei:AuditorName, dei:AuditorLocation, dei:AuditorFirmId, dei:DocumentPeriodEndDate)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://www.sec.gov/Archives/edgar/data/1703057/000170305726000012/abcl-20251231.htm",
    "state": "sourced",
    "value": "KPMG LLP"
   },
   "auditor_firm_id": {
    "read_by": "EDGAR 10-K cover page iXBRL tag (dei:AuditorName, dei:AuditorLocation, dei:AuditorFirmId, dei:DocumentPeriodEndDate)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://www.sec.gov/Archives/edgar/data/1703057/000170305726000012/abcl-20251231.htm",
    "state": "sourced",
    "value": "85"
   },
   "auditor_location": {
    "read_by": "EDGAR 10-K cover page iXBRL tag (dei:AuditorName, dei:AuditorLocation, dei:AuditorFirmId, dei:DocumentPeriodEndDate)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://www.sec.gov/Archives/edgar/data/1703057/000170305726000012/abcl-20251231.htm",
    "state": "sourced",
    "value": "Vancouver, Canada"
   },
   "changes": [
    {
     "date": "2025-11-28",
     "source": "https://www.sec.gov/Archives/edgar/data/1703057/000170305725000032/abcl-20251124.htm",
     "title": "8-K — 8-K (items 4.01,9.01)"
    }
   ]
  },
  "cmr": "us-cm-kg/NASDAQ/ABCL",
  "coverage": {
   "count": 0,
   "houses": [],
   "pages_checked": [],
   "read_by": "Perplexity sonar (search) · page read by this rail",
   "read_date": "2026-11-11",
   "since": null,
   "state": "none_found"
  },
  "disclosure": {
   "against": {
    "exchange": {
     "issuers": 4359,
     "median_cadence_gap_days": 6,
     "median_filings": 52,
     "median_latency_days": 5,
     "name": "NASDAQ"
    },
    "sector": {
     "issuers": 526,
     "median_cadence_gap_days": 6,
     "median_filings": 63,
     "median_latency_days": 4,
     "name": "2834 Pharmaceutical Preparations"
    }
   },
   "by_type": {
    "agm_egm": 3,
    "corporate_news": 7,
    "director_change": 4,
    "directors_dealings": 25,
    "prospectus": 2,
    "regulatory_filing": 3,
    "results": 6
   },
   "cadence_median_gap_days": 5.5,
   "filing_days": 29,
   "filings": 50,
   "latency_days": 76,
   "latest": [
    {
     "category": "4",
     "date": "2026-08-24",
     "source": "https://www.sec.gov/Archives/edgar/data/1703057/000162828026058684/xslF345X06/wk-form4_1787606506.xml",
     "title": "4 — FORM 4",
     "type": "directors_dealings"
    },
    {
     "category": "4",
     "date": "2026-08-18",
     "source": "https://www.sec.gov/Archives/edgar/data/1703057/000183442326000008/xslF345X06/wk-form4_1787078721.xml",
     "title": "4 — FORM 4",
     "type": "directors_dealings"
    },
    {
     "category": "4",
     "date": "2026-08-14",
     "source": "https://www.sec.gov/Archives/edgar/data/1703057/000183441126000008/xslF345X06/wk-form4_1786723463.xml",
     "title": "4 — FORM 4",
     "type": "directors_dealings"
    },
    {
     "category": "4",
     "date": "2026-08-14",
     "source": "https://www.sec.gov/Archives/edgar/data/1703057/000162828026057007/xslF345X06/wk-form4_1786722614.xml",
     "title": "4 — FORM 4",
     "type": "directors_dealings"
    },
    {
     "category": "4",
     "date": "2026-08-13",
     "source": "https://www.sec.gov/Archives/edgar/data/1703057/000162828026056653/xslF345X06/wk-form4_1786647701.xml",
     "title": "4 — FORM 4",
     "type": "directors_dealings"
    }
   ],
   "latest_filing_date": "2026-08-24",
   "read": "the node's event lines (list_events_since), as get_filings serves them",
   "source": "https://mcp.us-cm-kg.ai/events/NASDAQ/ABCL",
   "window": {
    "from": "2025-11-08",
    "to": "2026-11-08"
   }
  },
  "identity": {
   "exchange": {
    "read_by": "EDGAR company_tickers_exchange.json (SEC list of exchange-listed filers)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://www.sec.gov/files/company_tickers_exchange.json",
    "state": "sourced",
    "value": "NASDAQ"
   },
   "isin": {
    "read_by": "SEC Fails-to-Deliver data (CUSIP for the symbol) · ISIN = US + CUSIP + ISO 6166 check digit",
    "read_date": "2026-10-06",
    "read_date_basis": "last_seen",
    "source": "https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data",
    "state": "sourced",
    "value": "US00288U1060"
   },
   "jurisdiction": {
    "read_by": "EDGAR submissions API (issuer header as filed) (stateOfIncorporation)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0001703057.json",
    "state": "sourced",
    "value": "British Columbia, Canada"
   },
   "lei": {
    "market": "US",
    "reason": "no GLEIF record with the exact legal name in jurisdiction US-A1",
    "state": "not_on_record"
   },
   "name": {
    "read_by": "EDGAR submissions API (issuer header as filed)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0001703057.json",
    "state": "sourced",
    "value": "AbCellera Biologics Inc."
   },
   "sector": {
    "read_by": "EDGAR submissions API (issuer header as filed) (SIC code as assigned by the SEC)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0001703057.json",
    "state": "sourced",
    "value": "2834 Pharmaceutical Preparations"
   },
   "security_type": {
    "read_by": "EDGAR submissions API (issuer header as filed)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://data.sec.gov/submissions/CIK0001703057.json",
    "state": "sourced",
    "value": "Corporate"
   },
   "segment": {
    "market": "US",
    "state": "not_on_record"
   },
   "ticker": {
    "read_by": "EDGAR company_tickers_exchange.json (SEC list of exchange-listed filers)",
    "read_date": "2026-11-08",
    "read_date_basis": "the record version as_of",
    "source": "https://www.sec.gov/files/company_tickers_exchange.json",
    "state": "sourced",
    "value": "ABCL"
   },
   "website": {
    "market": "US",
    "state": "not_on_record"
   }
  },
  "licensed": {
   "columns": [
    "licensor",
    "entitlement",
    "title",
    "date",
    "source"
   ],
   "rows": [],
   "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded."
  },
  "lifecycle": {
   "delisting": [],
   "domicile_change": {
    "market": "US",
    "reason": "EDGAR states no dated change of state of incorporation on a filing line",
    "state": "not_on_record"
   },
   "listing": [],
   "name_change": [],
   "segment_move": {
    "market": "US",
    "reason": "the exchanges' tier transfers are not EDGAR filings",
    "state": "not_on_record"
   }
  },
  "market": "US",
  "node": "us-cm-kg",
  "numbers_hash": "sha256:dd72939d72d5fe63cfa09978a8f1c3bdd0b31cea505f6ef1264386eac409a692",
  "open_research": {
   "read_date": "2026-11-11",
   "rows": [],
   "state": "none_found"
  },
  "orderability": {
   "chapter_as_of": "2026-11-04",
   "client_categories": [],
   "determinable": false,
   "read": {
    "chapter": "https://mcp.us-cm-kg.ai/book/aio.json",
    "door": "https://mcp.us-cm-kg.ai/mcp",
    "tool": "get_orderability"
   },
   "reason": "the chapter's orderability section carries no client_categories: the outcome cannot name its client category",
   "rule_version": "acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1",
   "section": "us.aio.v8"
  },
  "record": {
   "as_of": "2026-11-08",
   "url": "https://mcp.us-cm-kg.ai/record/NASDAQ/ABCL",
   "version": 1
  },
  "schema": "research-numbers v0.1 (USR-01, 2026-11-11)",
  "status": {
   "read_date": "2026-11-08",
   "source": "https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts",
   "value": "listed, not halted"
  }
 },
 "numbers_hash": "sha256:dd72939d72d5fe63cfa09978a8f1c3bdd0b31cea505f6ef1264386eac409a692",
 "path": "/us/NASDAQ/ABCL",
 "schema": "research-page v0.1 (USR-02, 2026-11-11)",
 "sections": [
  {
   "id": "identity",
   "text": "The issuer is AbCellera Biologics Inc., listed on NASDAQ under ticker ABCL, with ISIN US00288U1060. The LEI is not on the record: no GLEIF record with the exact legal name in jurisdiction US-A1 was found. The security type is Corporate, the segment is not on the record, the sector is 2834 Pharmaceutical Preparations, and the jurisdiction is British Columbia, Canada. The issuer is listed and not halted.",
   "title": "Identity and listing"
  },
  {
   "id": "disclosure",
   "text": "The record holds 50 filings in the twelve months from 2025-11-08 to 2026-11-08, across 29 filing days. By type, the filings are 25 directors_dealings, 7 corporate_news, 6 results, 4 director_change, 3 agm_egm, 3 regulatory_filing and 2 prospectus. The median gap between filing days is 5.5 days. The latest filing is dated 2026-08-24, a directors_dealings filing, 76 days before the record date. On NASDAQ the median cadence gap is 6.0 days, the median filing count is 52, and the median latency is 5.0 days across 4359 issuers. In sector 2834 Pharmaceutical Preparations the median cadence gap is 6.0 days, the median filing count is 63.0, and the median latency is 4.0 days across 526 issuers.",
   "title": "The disclosure read"
  },
  {
   "id": "auditor",
   "text": "The auditor of record is KPMG LLP, located in Vancouver, Canada. The record shows one auditor change, dated 2025-11-28.",
   "title": "Auditor"
  },
  {
   "id": "events",
   "text": "The record holds no listing, delisting or name change lines. Domicile change is not on the record, because EDGAR states no dated change of state of incorporation on a filing line. Segment move is not on the record, because the exchanges' tier transfers are not EDGAR filings. The halt flag is listed, not halted.",
   "title": "Events and halts"
  },
  {
   "id": "orderability",
   "text": "The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.",
   "title": "Orderability"
  },
  {
   "id": "coverage",
   "text": "No research houses were found on the issuer's investor-relations pages read. The count is 0.",
   "title": "Coverage"
  },
  {
   "id": "open_research",
   "text": "No openly published research notes were found. The count is 0.",
   "title": "Open research"
  },
  {
   "id": "licensed",
   "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.",
   "title": "Licensed"
  },
  {
   "id": "depth",
   "text": "The issuer's years sealed are 2021, 2022, 2023, 2024, 2025 and 2026. The market's vintage is sealed, with the earliest sealed date of the market at 2021-01-04. The live record began on 2026-09-12.",
   "title": "As-of depth"
  },
  {
   "id": "sources",
   "text": "8 source pages are named on this page; every value above carries its own source page and read date in the numbers.",
   "title": "Sources"
  }
 ],
 "sources": [
  {
   "for": "identity.exchange",
   "source": "https://www.sec.gov/files/company_tickers_exchange.json"
  },
  {
   "for": "identity.isin",
   "source": "https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data"
  },
  {
   "for": "identity.jurisdiction",
   "source": "https://data.sec.gov/submissions/CIK0001703057.json"
  },
  {
   "for": "the disclosure lines",
   "source": "https://mcp.us-cm-kg.ai/events/NASDAQ/ABCL"
  },
  {
   "for": "the halt flag",
   "source": "https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts"
  },
  {
   "for": "the auditor",
   "source": "https://www.sec.gov/Archives/edgar/data/1703057/000170305726000012/abcl-20251231.htm"
  },
  {
   "for": "the orderability chapter",
   "source": "https://mcp.us-cm-kg.ai/book/aio.json"
  },
  {
   "for": "the record",
   "source": "https://mcp.us-cm-kg.ai/record/NASDAQ/ABCL"
  }
 ],
 "title": "AbCellera Biologics Inc. (ABCL) — research page",
 "writer": {
  "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers",
  "engine": "claude-haiku-5-5"
 }
}